Tags

Type your tag names separated by a space and hit enter

Laparoscopic Roux-en-Y gastric bypass in morbidly obese and super morbidly obese patients.
Am J Surg 2004; 187(2):230-2; discussion 232AJ

Abstract

BACKGROUND

Our objective was to compare the outcomes after laparoscopic Roux-en-Y gastric bypass (RYGB) in morbidly obese (body mass index [BMI] <50) patients with super morbidly obese (BMI >50) patients.

METHODS

A prospective analysis of 120 patients who underwent laparoscopic RYGB at a community based teaching hospital between January 2002 and August 2002 was performed. Sixty patients with BMI <50 were compared with 60 patients with BMI >50. Study endpoints included: operative time, length of stay, and overall complication rates including early (<7 days) and late (>7 days) complications.

RESULTS

Mean BMI in the obese group was 44.6 (range 39 to 49) versus 58.6 (range 50 to 100) in the superobese group. Medical comorbidities, age, and sex distribution were similar in both groups. Mean operative time in the obese group was 128 minutes (range 75 to 225) versus 144 minutes (range 75 to 240) in the superobese group. The overall complication rate was 10% in the obese group versus 20% in the superobese group. (P = 0.2) With regard to the obese group, the early complication rate was 5% (n = 3). These included 2 upper gastrointestinal bleeds and 1 respiratory failure. The late complication rate in this group was also 5% (n = 3). These were all anastomotic strictures requiring endoscopic dilation. In comparison, in the superobese group, the early complication rate was 8% (n = 5). These included 2 upper gastrointestinal bleeds, 1 pneumonia, 1 superficial wound infection, and 1 small bowel obstruction. The late complication rate in this group was 12% (n = 7). These included 4 anastomotic strictures, 1 incisional hernia, 1 pulmonary embolism, and 1 anastomotic leak. There were no conversions to open gastric bypass or deaths in either group. Median length of stay in both groups was 2 days.

CONCLUSIONS

Our data demonstrate no significant difference in operative times, complication rates or length of stay between morbidly obese and super morbidly obese patients undergoing laparoscopic RYGB. Laparoscopic RYGB is safe and technically feasible in the super morbidly obese patient population.

Authors+Show Affiliations

Department of Surgery, Baylor University Medical Center, 3409 Worth St., Suite 420, Dallas, TX 75246, USA.No affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article

Language

eng

PubMed ID

14769310

Citation

Dresel, Alexandra, et al. "Laparoscopic Roux-en-Y Gastric Bypass in Morbidly Obese and Super Morbidly Obese Patients." American Journal of Surgery, vol. 187, no. 2, 2004, pp. 230-2; discussion 232.
Dresel A, Kuhn JA, McCarty TM. Laparoscopic Roux-en-Y gastric bypass in morbidly obese and super morbidly obese patients. Am J Surg. 2004;187(2):230-2; discussion 232.
Dresel, A., Kuhn, J. A., & McCarty, T. M. (2004). Laparoscopic Roux-en-Y gastric bypass in morbidly obese and super morbidly obese patients. American Journal of Surgery, 187(2), pp. 230-2; discussion 232.
Dresel A, Kuhn JA, McCarty TM. Laparoscopic Roux-en-Y Gastric Bypass in Morbidly Obese and Super Morbidly Obese Patients. Am J Surg. 2004;187(2):230-2; discussion 232. PubMed PMID: 14769310.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Laparoscopic Roux-en-Y gastric bypass in morbidly obese and super morbidly obese patients. AU - Dresel,Alexandra, AU - Kuhn,Joseph A, AU - McCarty,Todd M, PY - 2003/07/11/received PY - 2003/08/21/revised PY - 2004/2/11/pubmed PY - 2004/4/2/medline PY - 2004/2/11/entrez SP - 230-2; discussion 232 JF - American journal of surgery JO - Am. J. Surg. VL - 187 IS - 2 N2 - BACKGROUND: Our objective was to compare the outcomes after laparoscopic Roux-en-Y gastric bypass (RYGB) in morbidly obese (body mass index [BMI] <50) patients with super morbidly obese (BMI >50) patients. METHODS: A prospective analysis of 120 patients who underwent laparoscopic RYGB at a community based teaching hospital between January 2002 and August 2002 was performed. Sixty patients with BMI <50 were compared with 60 patients with BMI >50. Study endpoints included: operative time, length of stay, and overall complication rates including early (<7 days) and late (>7 days) complications. RESULTS: Mean BMI in the obese group was 44.6 (range 39 to 49) versus 58.6 (range 50 to 100) in the superobese group. Medical comorbidities, age, and sex distribution were similar in both groups. Mean operative time in the obese group was 128 minutes (range 75 to 225) versus 144 minutes (range 75 to 240) in the superobese group. The overall complication rate was 10% in the obese group versus 20% in the superobese group. (P = 0.2) With regard to the obese group, the early complication rate was 5% (n = 3). These included 2 upper gastrointestinal bleeds and 1 respiratory failure. The late complication rate in this group was also 5% (n = 3). These were all anastomotic strictures requiring endoscopic dilation. In comparison, in the superobese group, the early complication rate was 8% (n = 5). These included 2 upper gastrointestinal bleeds, 1 pneumonia, 1 superficial wound infection, and 1 small bowel obstruction. The late complication rate in this group was 12% (n = 7). These included 4 anastomotic strictures, 1 incisional hernia, 1 pulmonary embolism, and 1 anastomotic leak. There were no conversions to open gastric bypass or deaths in either group. Median length of stay in both groups was 2 days. CONCLUSIONS: Our data demonstrate no significant difference in operative times, complication rates or length of stay between morbidly obese and super morbidly obese patients undergoing laparoscopic RYGB. Laparoscopic RYGB is safe and technically feasible in the super morbidly obese patient population. SN - 0002-9610 UR - https://www.unboundmedicine.com/medline/citation/14769310/Laparoscopic_Roux_en_Y_gastric_bypass_in_morbidly_obese_and_super_morbidly_obese_patients_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0002961003004069 DB - PRIME DP - Unbound Medicine ER -